Search
Ligand Pharmaceuticals Inc
LGNDAdd to Watchlist
295.920USD
+11.010+3.86%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
5.85BMarket Cap
38.56P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Contract Revenue- Other
66.87M
24.94%
Captisol
40.21M
15.00%
Kyprolis
35.53M
13.25%
Filspari
31.97M
11.93%
Qarziba
23.74M
8.85%
Other
69.76M
26.02%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Contract Revenue- Other
66.87M
24.94%
Captisol
40.21M
15.00%
Kyprolis
35.53M
13.25%
Filspari
31.97M
11.93%
Qarziba
23.74M
8.85%
Other
69.76M
26.02%
